PIII Multiplikator P/S P3 Health Partners

Logo korporat perusahaan P3 Health Partners, Inc. (PIII)

P3 Health Partners Inc. (PIII) attracts qualified medical professionals and analysts through a privilege system. Long-term contracts with insurance companies ensure a stable income stream. However, rising clinic costs have limited operating leverage, as confirmed by the revenue multiple. The current status is 0.00, while the coefficient dynamics on this chart help assess the level of investor confidence in the company's sales.

Multiplikator P/S: P3 Health Partners (PIII) kanggo 04.07.2022 - 13.11.2026

Rincian analitis perusahaan P3 Health Partners Inc.

- nilai saham lan prakiraan konsensus rega:
Analisis dhasar perusahaan:PIII (P3 Health Partners, Inc.)
Produk asli P3 Health Partners Inc.

An analysis of the price-to-sales ratio for P3 Health Partners Inc. (PIII) reflects the market's valuation of cost management efficiency within Medicare Advantage. This multiple relates current market capitalization to the volume of generated revenue, determining the cost of each unit of sales. The calculation allows for the identification of whether the asset is overbought or if its operating margins are undervalued. This helps investors assess the business's resilience to fluctuations in medical expenses and the accuracy of the clinics' forecasting.

Pesaing utama

Multiplikator P/S hcahealthcare.com (HCA)|Rasio kapitalisasi pasar marang pendapatan Tenet Healthcare Corporation|Multiplikator P/S Fresenius Medical Care AG FMS|SOLV (Solventum Inc.) - Rega marang dodolan|EHC - Multiplikator P/S|UHS: Multiplikator P/S|DVA (davita.com) - Rasio rega marang pendapatan|Rasio rega marang pendapatan RadNet|Kapitalisasi marang pendapatan Option Care (OPCH)|Kapitalisasi marang volume dodolan Surgery Partners Corp|Multiplikator P/S Premier Health (PINC)|Rasio kapitalisasi pasar marang pendapatan National Vision Holdings|PGNY - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan Ardent Health Partners (ARDT)|SEM: Rasio rega marang pendapatan|Rasio rega marang dodolan Apollo Medical Holdings (ASTH)|MEDNAX (MD) - Multiplikator P/S|USPH (US Physical Therapy) - Multiplikator P/S|Rasio rega marang pendapatan PNTG|Organogenesis (ORGO) - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan Nutex Health Inc NUTX|Kapitalisasi marang volume dodolan Auna Health (AUNA)|SBC Medical Group Holdings - Rasio rega marang pendapatan|Evolus, Inc. (EOLS) - Rasio kapitalisasi marang pendapatan|CYH - Multiplikator P/S|Rega marang dodolan SKIN|MDWD (MediWound) - Rasio rega marang pendapatan|BTMD - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan JYNT|DCGO (DocGo Inc.) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan gaintherapeutics.com GANX|Rasio kapitalisasi pasar marang pendapatan EUDA Health Holdings Limited|Multiplikator P/S Basel Medical BMGL|Koefisien rega marang pendapatan CLGN (CollPlant Ltd)|CUPR: Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan Concord Medical Services|ashs.com (AMS) - Multiplikator P/S|Kapitalisasi marang pendapatan MRM|Kapitalisasi marang pendapatan Avalon GloboCare Corporation (ALBT)|DHAI (DIH Holding US Inc.) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan XAGE (Carmell Corp)|NewGenIvf Group Limited (NIVF) - Rasio rega marang dodolan|Multiplikator P/S ATI Physical Therapy Inc. ATIP|Koefisien rega marang pendapatan CMAX (CareMax)|KDLY - Multiplikator P/S|LogistiCare - Koefisien rega marang pendapatan|Novo Integrated Sciences Corp (NVOS) - Multiplikator P/S|SSY: Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan imacholdings.comm (BACK)